Ramona Danac

Dr. Ramona Danac

Chemistry Department, Alexandru Ioan Cuza University, Iaşi, Romania
orcid
Alexandru Ioan Cuza University of Iasi, Faculty of Chemistry

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Ramona DanacRamona Danac
Ramona Danac
CMCristina M. Al Matarneh
Cristina M. Al Matarneh
SSSergiu Shova
Sergiu Shova
TDTeofil Daniloaia
Teofil Daniloaia
MBMihaela Balan-Porcarasu
Mihaela Balan-Porcarasu
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu

1 January 2017 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
AOAnda-Mihaela Olaru
Anda-Mihaela Olaru
VVVioleta Vasilache
Violeta Vasilache
Ramona DanacRamona Danac
Ramona Danac
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu
A series of 13 compounds having a monoindolizine mono-salt skeleton was designed and synthesised in order to evaluate their antimycobacterial activity. The synthesis is efficient, involving only three steps: two alkylations and one 3 + 2 dipolar cycloaddition. The antimicrobial activity against Mycobacterium tuberculosis H37Rv grown under aerobic conditions was evaluated, eight compounds showing a very good antimycobacterial activity. SAR correlation reveals a certain influence of the R substituent from the para position of benzoyl moiety at position 3 of indolizine. The most active five compounds passed the second stage of anti-TB testing, the assay demonstrating that they are potent against both replicating and non-replicating Mtb, have a bactericidal mechanism of action, are active against drug-resistant Mtb strains, present a moderate to good activity against nontuberculous mycobacteria, a good intracellular activity, and a moderate to high cytotoxicity. For one compound showing a promising anti-TB profile, a complete ADMET study has been performed.

1 January 2019 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
LPLacramioara Popovici
Lacramioara Popovici
RARoxana-Maria Amarandi
Roxana-Maria Amarandi
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu
VMVioleta Mangalagiu
Violeta Mangalagiu
Ramona DanacRamona Danac
Ramona Danac
Two new series of heterocyclic derivatives with potential anticancer activity, in which a pyrrolo[1,2-b]pyridazine or a pyrrolo[2,1-a]phthalazine moiety was introduced in place of the 3′-hydroxy-4′-methoxyphenyl ring of phenstatin have been synthesised and their structure-activity relationship (SAR) was studied. Fourteen of the new compounds were evaluated for their in vitro cytotoxic activity by National Cancer Institute (NCI) against 60 human tumour cell lines panel. The best five compounds in terms of in vitro growth inhibition were screened in the second stage five dose-response studies, three of them showing a very good antiproliferative activity with GI50<100 nM on several cell lines including colon, ovarian, renal, prostate, brain and breast cancer, melanoma and leukemia. Docking experiments on the biologically active compounds showed a good compatibility with the colchicine binding site of tubulin.

3 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
CACristina Maria Al-Matarneh
Cristina Maria Al-Matarneh
RARoxana-Maria Amarandi
Roxana-Maria Amarandi
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu
Ramona DanacRamona Danac
Ramona Danac
Several new cyano-substituted derivatives with pyrrolo[1,2-a]quinoline and pyrrolo[2,1-a]isoquinoline scaffolds were synthesized by the [3 + 2] cycloaddition of (iso)quinolinium ylides to fumaronitrile. The cycloimmonium ylides reacted in situ as 1,3-dipoles with fumaronitrile to selectively form distinct final compounds, depending on the structure of the (iso)quinolinium salt. Eleven compounds were evaluated for their anticancer activity against a panel of 60 human cancer cell lines. The most potent compound 9a showed a broad spectrum of antiproliferative activity against cancer cell lines representing leukemia, melanoma and cancer of lung, colon, central nervous system, ovary, kidney, breast and prostate cancer. In vitro assays and molecular docking revealed tubulin interaction properties of compound 9a.

7 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
DADORINA AMARIUCAI-MANTU
DORINA AMARIUCAI-MANTU
VMVioleta Mangalagiu
Violeta Mangalagiu
Ramona DanacRamona Danac
Ramona Danac
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu
Microwave (MW) assisted reactions have became a powerful tool in azaheterocycles chemistry during the last decades. Five and six membered ring azaheterocycles are privileged scaffolds in modern medicinal chemistry possessing a large variety of biological activity. This review is focused on the recent relevant advances in the MW assisted reactions applied to azaheterocyclic derivatives and their medicinal chemistry applications from the last five years. The review is divided according to the main series of azaheterocycles, more precisely 5- and 6-membered ring azaheterocycles (with one, two, and more heteroatoms) and their fused analogues. In each case, the reaction pathways, the advantages of using MW, and considerations concerning biological activity of the obtained products were briefly presented.

Verified
Journal Article
Open access
PDF file
LOLiliana Oniciuc
Liliana Oniciuc
DADORINA AMARIUCAI-MANTU
DORINA AMARIUCAI-MANTU
DDDumitrela Diaconu
Dumitrela Diaconu
VMVioleta Mangalagiu
Violeta Mangalagiu
Ramona DanacRamona Danac
Ramona Danac
Ionel I. MangalagiuIonel I. Mangalagiu
Ionel I. Mangalagiu
This study presents the synthesis, structural characterization, and in vitro evaluation of anticancer activity of some newly benzo[f]quinoline derivatives. The synthesis is facile and efficient, involving two steps: quaternization of nitrogen heterocycle followed by a [3+2] dipolar cycloaddition reaction. The synthesized compounds were characterized by FTIR, NMR, and X-ray diffraction on monocrystal in the case of compounds 6c and 7c. An in vitro single-dose anticancer assay of eighteen benzo[f]quinoline compounds, quaternary salts, and cycloadducts, was performed. The results showed that the most active compounds were quaternary salts 3d and 3f with aromatic R substituents. Quaternary salt 3d revealed non-selective activity against all types of cancer cells, while salt 3f exhibited a highly selective activity against leukemia cells. Compound 3d also presented remarkable cytotoxic efficiency against four distinct types of cancer cells—namely, non-small cell lung cancer HOP–92, melanoma LOX IMVI, melanoma SK–MEL–5, and breast cancer MDA–MB–468. Compound 3f was selected for five-dose screening. The study also includes SAR correlations.